Researchers at Fox Chase Cancer Center have identified the protein anoctamin 6, or ANO6, as a potential therapeutic target that could simultaneously slow tumor growth and reduce immune suppression in pancreatic cancer, according to a study published in Nature Cancer. The findings demonstrate how pancreatic cancer cells scavenge essential nutrients from surrounding tissue while evading the body’s natural defenses.
Targeting ANO6 in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma, the most common form of the disease, grows within a uniquely dense environment characterized by tight connective tissue and collapsed, non-functional blood vessels. Because these tumors lack adequate blood supply, scientists have long questioned how cancer cells manage to obtain the nutrients required for rapid survival and proliferation. Recent experiments reveal that cancer-associated fibroblasts (CAFs)—cells that form the bulk of the tumor’s surrounding stroma—actively feed the cancer.
According to co-senior study author Igor Astsaturov, a professor at Fox Chase, CAFs act as a direct metabolic resource. The research shows that CAF units pull cholesterol from the bloodstream and deliver it to nearby pancreatic cancer cells through trogocytosis. During this cellular transaction, cancer cells strip small pieces of membrane directly from the fibroblasts, acquiring vital lipids in the process. The entire transfer mechanism relies on ANO6 to prepare the fibroblast membrane for successful detachment and fusion.
How Fibroblasts Weaken Cytotoxic T Lymphocytes
Beyond starving the body of resources through direct feeding, the same membrane-sharing mechanism actively disables the immune system. CAFs form direct contacts with cytotoxic T lymphocytes, which are the immune cells responsible for recognizing and destroying malignant cells. During these interactions, T cells also acquire portions of the fibroblast membrane along with excess cholesterol. High concentrations of cholesterol inside tumor-infiltrating T cells lead to exhaustion, diminishing their ability to fight off the cancer.
When researchers eliminated or reduced ANO6 function in laboratory and animal models, tumors grew substantially slower than those driven by functional ANO6. Furthermore, blocking the protein reduced cholesterol accumulation inside T cells, restored markers of healthy immune activity, and increased the cancer-killing potency of T lymphocytes exposed to CAFs.
Preclinical Results Using Niclosamide and Clofazimine
To test whether disrupting ANO6 could yield tangible therapeutic benefits, the research team administered existing drugs known to inhibit ANO6-dependent activity. In mouse models, treatment with niclosamide or clofazimine significantly reduced overall tumor weight. Specifically, niclosamide suppressed the delivery of cholesterol from the stroma to the malignant cells.
Edna Cukierman, professor and co-leader of the Cancer Signaling and Microenvironment Program at Fox Chase and co-senior author of the study, noted that targeting ANO6 disrupts the stromal synapse-mimicry circuit that coordinates nutritional support and immune suppression. Because trogocytosis represents just one of several pathways cancer cells use to harvest lipids, the team emphasizes that further investigation is required before clinical strategies targeting ANO6 can be fully established for human patients.
Frequently Asked Questions About the ANO6 Study
What specific role does anoctamin 6 play in tumor microenvironments?
Anoctamin 6 prepares the cell membranes of cancer-associated fibroblasts so they can transfer lipids, such as cholesterol, to pancreatic cancer cells via trogocytosis while simultaneously exhausting tumor-fighting T cells.
Which drugs were tested to inhibit ANO6 activity in the study?
Researchers tested niclosamide and clofazimine in mouse models, finding that both drugs suppressed ANO6-dependent activity and significantly reduced tumor mass.
Why is nutrient acquisition particularly difficult in pancreatic ductal adenocarcinoma?
Pancreatic ductal adenocarcinoma is surrounded by dense connective tissue and features very few functional blood vessels because they collapse under the pressure of expanding fibroblast units and collagen fibers.
Worth a look